Alana L Welm Selected Research

macrophage stimulating protein

1/2017	RON kinase: A target for treatment of cancer-induced bone destruction and osteoporosis.
7/2013	Inhibition of ron kinase blocks conversion of micrometastases to overt metastases by boosting antitumor immunity.
9/2010	The macrophage stimulating protein/Ron pathway as a potential therapeutic target to impede multiple mechanisms involved in breast cancer progression.
5/2007	The macrophage-stimulating protein pathway promotes metastasis in a mouse model for breast cancer and predicts poor prognosis in humans.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alana L Welm Research Topics

Disease

43	Neoplasms (Cancer) 10/2022 - 03/2005
31	Breast Neoplasms (Breast Cancer) 01/2022 - 03/2005
19	Neoplasm Metastasis (Metastasis) 01/2021 - 05/2007
6	Triple Negative Breast Neoplasms 01/2021 - 06/2013
2	Tics (Tic) 01/2021 - 01/2018
2	Melanoma (Melanoma, Malignant) 01/2019 - 09/2013
2	Carcinogenesis 11/2018 - 04/2009
2	Carcinoma (Carcinomatosis) 09/2016 - 09/2009
1	Adenocarcinoma 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 01/2019
1	Osteolysis 01/2017
1	Osteoporosis 01/2017
1	Genetic Translocation (Chromosomal Translocation) 09/2014
1	Lobular Carcinoma 03/2014
1	Ductal Carcinoma 03/2014
1	Neoplasm Micrometastasis 07/2013
1	Residual Neoplasm 06/2013
1	Hematologic Neoplasms (Hematological Malignancy) 03/2012
1	Ewing Sarcoma (Sarcoma, Ewing) 02/2012

Drug/Important Bio-Agent (IBA)

12	Phosphotransferases (Kinase)IBA 12/2021 - 04/2009
6	LigandsIBA 12/2021 - 01/2017
6	Biomarkers (Surrogate Marker)IBA 01/2019 - 05/2007
5	Proteins (Proteins, Gene)FDA Link 12/2021 - 07/2011
4	Pharmaceutical PreparationsIBA 01/2022 - 01/2018
4	Estrogen ReceptorsIBA 10/2021 - 05/2010
4	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2018 - 01/2014
4	macrophage stimulating proteinIBA 01/2017 - 05/2007
4	Indicators and Reagents (Reagents)IBA 01/2016 - 03/2005
4	IntegrinsIBA 09/2014 - 09/2011
3	RNA (Ribonucleic Acid)IBA 10/2020 - 01/2016
3	Transcription Factors (Transcription Factor)IBA 01/2018 - 02/2012
3	tyrosine receptor (receptor, tyrosine)IBA 01/2018 - 07/2011
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2022 - 07/2013
2	Protein Isoforms (Isoforms)IBA 12/2021 - 07/2011
2	Estrogens (Estrogen)FDA Link 10/2021 - 03/2014
2	Hormones (Hormone)IBA 10/2021 - 03/2005
2	Peptides (Polypeptides)IBA 01/2020 - 01/2018
2	Oncogene Proteins (Oncogene Protein)IBA 01/2019 - 04/2009
2	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 03/2012
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2018 - 05/2010
2	Messenger RNA (mRNA)IBA 06/2013 - 01/2012
2	Transforming Growth Factor beta (TGF-beta)IBA 09/2009 - 04/2008
2	Homeodomain Proteins (Proteins, Homeobox)IBA 09/2009 - 09/2009
1	RON proteinIBA 01/2022
1	CyclinsIBA 01/2022
1	Estrogen Receptor alphaIBA 12/2021
1	epsinIBA 01/2021
1	Aromatase InhibitorsIBA 01/2021
1	Notch ReceptorsIBA 01/2021
1	BLU9931IBA 01/2021
1	Phenobarbital (Luminal)FDA Link 01/2021
1	ABT-414IBA 11/2020
1	navitoclaxIBA 11/2020
1	ErbB Receptors (EGF Receptor)IBA 11/2020
1	Immunoconjugates (Immunoconjugate)IBA 11/2020
1	Slit homolog 2 proteinIBA 10/2020
1	A-Form DNA (A-DNA)IBA 01/2020
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2020
1	AntigensIBA 01/2020
1	VaccinesIBA 01/2020
1	EpitopesIBA 01/2020
1	Chloroquine (Aralen)FDA LinkGeneric 01/2019
1	Trastuzumab (Herceptin)FDA Link 01/2019
1	trametinibIBA 01/2019
1	TRPA1 Cation ChannelIBA 11/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2018
1	Immune Checkpoint InhibitorsIBA 01/2018
1	Tumor Viral Antigens (Large T Antigen)IBA 01/2018
1	Ribosomal Protein S6IBA 01/2018
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2018
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2018
1	Everolimus FDA Link 01/2018
1	N- (4- (2- amino- 3- chloropyridin- 4- yloxy)- 3- fluorophenyl)- 4- ethoxy- 1- (4- fluorophenyl)- 2- oxo- 1,2- dihydropyridine- 3- carboxamideIBA 01/2017
1	Diphosphonates (Bisphosphonates)IBA 01/2017
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 09/2016
1	Cetuximab (Erbitux)FDA Link 09/2016
1	CarcinogensIBA 05/2016
1	MicroRNAs (MicroRNA)IBA 01/2016
1	Conditioned Culture MediaIBA 01/2016
1	NVP-BKM120IBA 12/2015
1	Biological ProductsIBA 04/2015
1	ZyxinIBA 09/2014
1	Tamoxifen FDA LinkGeneric 03/2014
1	PlasticsIBA 09/2013
1	SurvivinIBA 09/2013
1	AgarIBA 09/2013
1	Fibronectins (Fibronectin)IBA 09/2013
1	Monoclonal AntibodiesIBA 06/2013
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 06/2013
1	Decitabine FDA Link 03/2012
1	Azacitidine (5 Azacytidine)FDA Link 03/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2012
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2012

Therapy/Procedure

25	Therapeutics 10/2022 - 09/2010
5	Drug Therapy (Chemotherapy) 01/2021 - 08/2011
4	Precision Medicine 10/2022 - 03/2013
4	Immunotherapy 12/2021 - 01/2018
2	Transplantation 03/2013 - 03/2005
1	Intraperitoneal Injections 09/2013
1	Radioimmunotherapy 06/2013